Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Prediction of Acute Kidney Injury After Operation of Acute Type A Aortic Dissection Based on Multimodal Model
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 242
- Registration Number
- NCT05017896
Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 89
- Registration Number
- NCT05017922
- Locations
- 🇨🇳
Qilu Hospital , Shandong University, Jinan, Shandong, China
Tourniquet vs. no Tourniquet During High Tibial Osteotomy
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 50
- Registration Number
- NCT04992533
- Locations
- 🇨🇳
Qilu hospital of Shandong University, Jinan, Shandong, China
Quantitative Analysis of Functional CT Imaging of Coronary Atherosclerosis
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 640
- Registration Number
- NCT04986410
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Safety of Anticoagulant Therapy After Endoscopic Treatment
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 86
- Registration Number
- NCT04976543
- Locations
- 🇨🇳
Department of Gastroenterology,Qilu Hospital,Shandong University, Jinan, Shandong, China
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT04976465
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Rapid Identification of MINOCA Based on Novel Biomarkers
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2021-07-23
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 2616
- Registration Number
- NCT04974320
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking Imaging
- Conditions
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT04969055
- Locations
- 🇨🇳
Qilu Hospital , Shandong University, Jinan, Shandong, China
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 100
- Registration Number
- NCT04928066
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Immunosuppressant Combined With Pirfenidone in CTD-ILD
Phase 4
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 200
- Registration Number
- NCT04928586
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
© Copyright 2024. All Rights Reserved by MedPath